Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer

European Journal of Surgical Oncology

Volumn 40, Issue 10, 2014, Pages 1338-1345

  Koeter M ^a   Van Steenbergen, L N ^b   Lemmens, V E P P ^b,c   Rutten, H J T ^a,d   Roukema, J A ^e   Wijnhoven, B P L ^c   Nieuwenhuijzen, G A P ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Curative surgery; Hospital of diagnosis; Oesophageal cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSIS; ESOPHAGUS CANCER; FEMALE; HOSPITAL; HOSPITAL OF DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NETHERLANDS; OVERALL SURVIVAL; PATIENT CARE; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; SURVIVAL RATE; ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HEALTH CARE DISPARITY; MORTALITY; MULTIVARIATE ANALYSIS; PROBABILITY; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HEALTHCARE DISPARITIES; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION;

EID: 84925223393     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.12.024     Document Type: Article

References (30)

1. Comprehensive Cancer Centre Netherlands/Comprehensive Cancer Centre South. www.cijfersoverkanker.nl [assessed on 02.02.2013].
2. J.L. Dikken, V.E. Lemmens, and M.W. Wouters et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands Eur J Cancer 48 2012 1624 1632
3. National clinical practice guideline oesophageal cancer. www.oncoline.nl [assessed on 02.02.2013].
4. B. Berger, K. Stahlberg, A. Lemminger, M. Bleif, C. Belka, and M. Bamberg Impact of radiotherapy, chemotherapy and surgery in multimodal treatment of locally advanced esophageal cancer Oncology 81 2011 387 394
5. T.D. Crosby, A.E. Brewster, and A. Borley et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma Br J Cancer 90 2004 70 75
6. S. Gwynne, C. Hurt, M. Evans, C. Holden, L. Vout, and T. Crosby Definitive chemoradiation for oesophageal cancer - a standard of care in patients with non-metastatic oesophageal cancer Clin Oncol (R Coll Radiol) 23 2011 182 188
7. M.A. Morgan, W.G. Lewis, and A. Casbard et al. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma Br J Surg 96 2009 1300 1307
8. L.V. van de Poll-Franse, V.E. Lemmens, J.A. Roukema, J.W. Coebergh, and G.A. Nieuwenhuijzen Impact of concentration of oesophageal and gastric cardia cancer surgery on long-term population-based survival Br J Surg 98 2011 956 963
9. J.L. Dikken, A.E. Dassen, and V.E. Lemmens et al. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009 Eur J Cancer 48 2012 1004 1013
10. J.L. Dikken, J.W. van Sandick, and W.H. Allum et al. Differences in outcomes of oesophageal and gastric cancer surgery across Europe Br J Surg 100 2013 83 94
11. M.W. Wouters, G.A. Gooiker, J.W. van Sandick, and R.A. Tollenaar The volume-outcome relation in the surgical treatment of esophageal cancer: a systematic review and meta-analysis Cancer 118 2012 1754 1763
12. S. Burton, G. Brown, I.R. Daniels, A.R. Norman, B. Mason, and D. Cunningham MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer 94 2006 351 357
13. E.A. Newman, A.B. Guest, and M.A. Helvie et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board Cancer 107 2006 2346 2351
14. A.R. Davies, D.A. Deans, and I. Penman et al. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer Dis Esophagus 19 2006 496 503
15. P. van Hagen, M.C. Spaander, and A. van der Gaast et al. Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study Int J Clin Oncol 2013;18:214-9
16. UICC TNM classification of malignant tumours 6th ed. 2002 Wiley-Liss New York
17. A. Fritz, C. Percy, and A. Jack et al. International classification of diseases for oncology 3rd ed. 2000 World Health Organisation Geneva
18. M.L. Janssen-Heijnen, S. Houterman, V.E. Lemmens, M.W. Louwman, H.A. Maas, and J.W. Coebergh Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach Crit Rev Oncol Hematol 55 2005 231 240
19. Coen van Duin, and Ingeborg Keij Sociaal-economische status indicator op postcodeniveau. Maandstatistiek van de bevolking Jaargang 50 2002 32 35
20. E.P. van Vliet, M.J. Eijkemans, and E.J. Kuipers et al. A comparison between low-volume referring regional centers and a high-volume referral center in quality of preoperative metastasis detection in esophageal carcinoma Am J Gastroenterol 101 2006 234 242
21. E.P. van Vliet, J.J. Hermans, and W. De Wever et al. Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer Eur Radiol 18 2008 2475 2484
22. E.P. van Vliet, M.J. Eijkemans, J.W. Poley, E.W. Steyerberg, E.J. Kuipers, and P.D. Siersema Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers Gastrointest Endosc 63 2006 938 947
23. E.C. Paulson, J. Ra, K. Armstrong, C. Wirtall, F. Spitz, and R.R. Kelz Underuse of esophagectomy as treatment for resectable esophageal cancer Arch Surg 143 2008 1198 1203
24. L.B. Koppert, V.E. Lemmens, and J.W. Coebergh et al. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer Br J Surg 99 2012 1693 1700
25. E.P. van Vliet, M.J. Eijkemans, and E.W. Steyerberg et al. The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in the Netherlands Br J Cancer 95 2006 1180 1185
26. P. Bus, M.J. Aarts, and V.E. Lemmens et al. The effect of socioeconomic status on staging and treatment decisions in esophageal cancer J Clin Gastroenterol 2012;46:833-9
27. R.P. Merkow, K.Y. Bilimoria, and M.D. McCarter et al. Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States Cancer 2012;118:3268-76
28. H.H. Yoon, M. Khan, and Q. Shi et al. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection Mayo Clin Proc 85 2010 1080 1089
29. L. Bedenne, P. Michel, and O. Bouché et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 2007 1160 1168
30. M. Stahl, M. Stuschke, and N. Lehmann et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2005 2310 2317